You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

pegfilgrastim

( peg-fill-GRA-stim )
Funding:
ODB - General Benefit
  • pegfilgrastim - Lapelga brand
  • pegfilgrastim - Fulphila brand
  • pegfilgrastim - Ziextenzo brand
Other Name(s): Neulasta®; Lapelga™; Fulphila™; Ziextenzo®
Appearance: Clear, colourless solution for injection in a pre-filled syringe

Patient Info Sheet

May 2020

What it is used for

  • Pegfilgrastim is the long-acting form of filgrastim, used to stimulate the growth of white blood cells.
  • Chemotherapy drugs often slow down the growth of new white blood cells, resulting in a higher chance of infection and delays in the recovery of blood counts. Pegfilgrastim is used to stimulate the growth of white blood cells.
     
  • Pegfilgrastim is available as a biosimilar medication. See our biosimilar pamphlet for more information.


You might also be interested in